Purple Biotech's total assets for Q4 2024 were $37.04M, an increase of 5.51% from the previous quarter. PPBT total liabilities were $4.13M for the fiscal quarter, a -26.80% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.